Cargando…

Protective Effect of Nebivolol against Oxidative Stress Induced by Aristolochic Acids in Endothelial Cells

Aristolochic acids (AAs) are powerful nephrotoxins that cause severe tubulointerstitial fibrosis. The biopsy-proven peritubular capillary rarefaction may worsen the progression of renal lesions via tissue hypoxia. As we previously observed the overproduction of reactive oxygen species (ROS) by cultu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antoine, Marie-Hélène, Husson, Cécile, Yankep, Tatiana, Mahria, Souhaila, Tagliatti, Vanessa, Colet, Jean-Marie, Nortier, Joëlle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876861/ https://www.ncbi.nlm.nih.gov/pubmed/35202159 http://dx.doi.org/10.3390/toxins14020132

Ejemplares similares

Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition
por: Baudoux, Thomas, et al.
Publicado: (2022)

CD4(+) and CD8(+) T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy
por: Baudoux, Thomas, et al.
Publicado: (2018)

An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature
por: Jadot, Inès, et al.
Publicado: (2017)

The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro
por: Sborchia, Mateja, et al.
Publicado: (2019)

Nephroprotective Effects of Two Ganoderma Species Methanolic Extracts in an In Vitro Model of Cisplatin Induced Tubulotoxicity
por: Sinaeve, Sébastien, et al.
Publicado: (2022)

Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy
por: Jadot, Inès, et al.
Publicado: (2017)

Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats
por: Pozdzik, Agnieszka A., et al.
Publicado: (2016)

GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells
por: Dallons, Matthieu, et al.
Publicado: (2020)

Targeting Metabolic Reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach
por: Draguet, Anaïs, et al.
Publicado: (2021)

Predicting Valproate-Induced Liver Injury Using Metabolomic Analysis of Ex Ovo Chick Embryo Allantoic Fluid
por: Tagliatti, Vanessa, et al.
Publicado: (2023)

Nebivolol: impact on cardiac and endothelial function and clinical utility
por: Toblli, Jorge Eduardo, et al.
Publicado: (2012)

Effects of Nebivolol on Endothelial Gene Expression during Oxidative Stress in Human Umbilical Vein Endothelial Cells
por: Garbin, Ulisse, et al.
Publicado: (2008)

New Insights About Doxorubicin-Induced Toxicity to Cardiomyoblast-Derived H9C2 Cells and Dexrazoxane Cytoprotective Effect: Contribution of In Vitro (1)H-NMR Metabonomics
por: Dallons, Matthieu, et al.
Publicado: (2020)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
por: Fortepiani, L.A., et al.
Publicado: (2002)

The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells
por: Mason, R Preston, et al.
Publicado: (2013)

Influence of Nutritional Intake of Carbohydrates on Mitochondrial Structure, Dynamics, and Functions during Adipogenesis
por: Delcourt, Manon, et al.
Publicado: (2020)

Investigation of Mitochondrial Adaptations to Modulation of Carbohydrate Supply during Adipogenesis of 3T3-L1 Cells by Targeted (1)H-NMR Spectroscopy
por: Delcourt, Manon, et al.
Publicado: (2021)

Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
por: Mohamed, Enas Ahmed, et al.
Publicado: (2018)

Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome
por: Mercanoglu, Guldem, et al.
Publicado: (2019)

Data of Nebivolol on oxidative stress parameters in hypertensive patients
por: Barroso, Helena C., et al.
Publicado: (2022)

Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
por: Nascimento, Mariana Moura, et al.
Publicado: (2022)

Smad7 protects against chronic aristolochic acid nephropathy in mice
por: Dai, Xiao-Yu, et al.
Publicado: (2015)

Protective Effects of Melatonin Against Aristolochic Acid-Induced Nephropathy in Mice
por: Kim, Jung-Yeon, et al.
Publicado: (2019)

Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage
por: Coats, A, et al.
Publicado: (2017)

Protective effect of nebivolol on rat ovary exposed to deltamethrin toxicity
por: Otçu, Serap, et al.
Publicado: (2023)

Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling
por: Zhang, Zheng, et al.
Publicado: (2014)

Effects of Nebivolol on Endothelial Function and Exercise Parameters in Patients with Slow Coronary Flow
por: Tiryakioglu, Selma, et al.
Publicado: (2009)

Nebivolol for improving endothelial dysfunction in cardiac syndrome-x; Is it ready for clinical use?
por: Fatahian, Alireza
Publicado: (2019)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
por: Rousselin, Yoann, et al.
Publicado: (2012)

Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)

Aristolochic acid exposure in Romania and implications for renal cell carcinoma
por: Turesky, Robert J, et al.
Publicado: (2016)

Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure
por: Stauffer, Brian L., et al.
Publicado: (2017)

Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension
por: Li, Bingwei, et al.
Publicado: (2020)

Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats
por: Bárta, František, et al.
Publicado: (2021)

Nebivolol in the treatment of chronic heart failure
por: Veverka, Angie, et al.
Publicado: (2007)

Influence of nebivolol on anticonvulsant effect of lamotrigine
por: Goel, Radha, et al.
Publicado: (2009)

Rhabdomyolysis in a patient taking nebivolol
por: Kim, Ye Jin, et al.
Publicado: (2016)

Hepatic and Renal Toxicity Induced by TiO(2) Nanoparticles in Rats: A Morphological and Metabonomic Study
por: Valentini, Xavier, et al.
Publicado: (2019)

Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
por: Anger, Etienne Empweb, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k27pn6sbhu25gi980pc1c2i1gl